Have a website account?
Log In
or
Register
for exclusive website content.
Subscribe
Advanced Search
Home
Journal Info
About
tlcr
Indexing
Editors-in-Chief
Editorial Board
Former Editorial Board
Testimonials
Peer Review Process
Supplements and Series
Advertising Policy
For Authors
Author Instructions
Online Submission
Submit Multimedia Files
Reference Style
AME Editing Service
Interviews with Outstanding Authors
For Reviewers
Guidelines for Reviewers
Online Review
Reviewers
Ethics and Policies
Journal Management (Editorial Roles)
Editorial Policies
Publication Ethics Policy
Research Ethics Policy
Human and Animal Rights
Authorship and Contributorship
Informed Consent Policy
Conflicts of Interest
Data Sharing Policy
Open Access Statement
Content Licensing
Copyright and Permission
Quality Control System
Data and Reproducibility
Policy of Screening for Plagiarism Process
Policy of Dealing with Allegations of Research Misconduct
Corrections and Retractions
Complaints and Appeals
Special Contents
Special Series (Published)
Special Series (Ongoing)
TLCR Chinese Edition
Interviews with Guest Editors
Interviews with Editorial Board Members
Archives
Online First
Article Processing Charges
News
Home
/
Vol 9, No 4 (August 28, 2020)
/
Adjuvant EGFR-TKIs-based therapy: are we ready?
Editorial
Adjuvant EGFR-TKIs-based therapy: are we ready?
Terence Tam
Article Options
PDF
488 views
Full Text
1020 views
COI Form
277 views
Download Citation
Bibtex
EndNote
ProCite
refMan
refWorks
Share
Share on Facebook
Share on Twitter
